Form D · Pharmaceuticals
Cynapsus Therapeutics Inc.
Toronto, A6 · CIK 0001532079
Offering snapshot reported Apr 14, 2015 · SEC filing
- Reported sold
- $16.8M Offering amount: $16.8M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 31, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 14, 2015 | Initial | $16,750,000 | No comparison | 14 | SEC filing |
| Apr 21, 2014 | Initial | $14,546,285 | No comparison | 19 | SEC filing |
| Mar 27, 2013 | Amendment | $4,124,454 | $201,264vs Mar 15, 2013 | 5 | SEC filing |
| Mar 20, 2013 | Initial | Yet to sell | No comparison | 10 | SEC filing |
| Mar 15, 2013 | Initial | $3,923,190 | No comparison | 5 | SEC filing |
| Mar 28, 2012 | Amendment | $939,505 | $177,895vs Jan 9, 2012 | 7 | SEC filing |
| Jan 9, 2012 | Amendment | $761,610 | $206,252vs Dec 28, 2011 | 6 | SEC filing |
| Dec 28, 2011 | Amendment | $555,358 | $166,214vs Nov 18, 2011 | 5 | SEC filing |
| Nov 18, 2011 | Amendment | $389,144 | $166,776vs Oct 13, 2011 | 3 | SEC filing |
| Oct 13, 2011 | Initial | $222,368 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1.01M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-237893
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Noble Financial Capital Markets | 15768 |
Source: Form D, filed Apr 14, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thierry Bilbault | Executive |
| Nathan Bryson | Executive |
| Anthony Giovinazzo | Director, Executive |
| Tomer Gold | Director |
| David Hill | Director |
| Ronald Hosking | Director |
| Tamar D. Howson | Director |
| Margaret Nan Hutchinson | Director |
| Nan Hutchinson | Director |
| Julia Levy | Director |
| Perry Molinoff | Director |
| Ilan Oren | Director |
| Alan D. C. Ryley | Director |
| Rochelle Stenzler | Director |
| Alan Torrie | Director |
| Andrew Williams | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
828 Richmond Street West
Toronto, A6, M6J 1C9
Toronto, A6, M6J 1C9